Search tips
Search criteria 


Logo of jnnpsycJournal of Neurology, Neurosurgery and PsychiatryVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Neurol Neurosurg Psychiatry. 2004 August; 75(8): 1093–1099.
PMCID: PMC1739176

Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline


Background: Dementia can be caused by severe niacin insufficiency, but it is unknown whether variation in intake of niacin in the usual diet is linked to neurodegenerative decline. We examined whether dietary intake of niacin was associated with incident Alzheimer's disease (AD) and cognitive decline in a large, prospective study.

Methods: This study was conducted in 1993–2002 in a geographically defined Chicago community of 6158 residents aged 65 years and older. Nutrient intake was determined by food frequency questionnaire. Four cognitive tests were administered to all study participants at 3 year intervals in a 6 year follow up. A total of 3718 participants had dietary data and at least two cognitive assessments for analyses of cognitive change over a median 5.5 years. Clinical evaluations were performed on a stratified random sample of 815 participants initially unaffected by AD, and 131 participants were diagnosed with 4 year incident AD by standardised criteria.

Results: Energy adjusted niacin intake had a protective effect on development of AD and cognitive decline. In a logistic regression model, relative risks (95% confidence intervals) for incident AD from lowest to highest quintiles of total niacin intake were: 1.0 (referent) 0.3 (0.1 to 0.6), 0.3 (0.1 to 0.7), 0.6 (0.3 to 1.3), and 0.3 (0.1 to 0.7) adjusted for age, sex, race, education, and ApoE e4 status. Niacin intake from foods was also inversely associated with AD (p for linear trend = 0.002 in the adjusted model). In an adjusted random effects model, higher food intake of niacin was associated with a slower annual rate of cognitive decline, by 0.019 standardised units (SU) per natural log increase in intake (mg) (p = 0.05). Stronger associations were observed in analyses that excluded participants with a history of cardiovascular disease (ß = 0.028 SU/year; p = 0.008), those with low baseline cognitive scores (ß = 0.023 SU/year; p = 0.02), or those with fewer than 12 years' education (ß = 0.035 SU/year; p = 0.002)

Conclusion: Dietary niacin may protect against AD and age related cognitive decline.

Full Text

The Full Text of this article is available as a PDF (106K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Chong Zhao Zhong, Lin Shi-Hua, Maiese Kenneth. Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endothelial cell injury. J Vasc Res. 2002 Mar-Apr;39(2):131–147. [PubMed]
  • Rawling JM, Jackson TM, Driscoll ER, Kirkland JB. Dietary niacin deficiency lowers tissue poly(ADP-ribose) and NAD+ concentrations in Fischer-344 rats. J Nutr. 1994 Sep;124(9):1597–1603. [PubMed]
  • Hageman GJ, Stierum RH. Niacin, poly(ADP-ribose) polymerase-1 and genomic stability. Mutat Res. 2001 Apr 18;475(1-2):45–56. [PubMed]
  • Nakashima Y, Suzue R. Influence of nicotinic acid on cerebroside synthesis in the brain of developing rats. J Nutr Sci Vitaminol (Tokyo) 1984 Dec;30(6):525–534. [PubMed]
  • Nakashima Y, Esashi T. Effect of 3-acetylpyridine on the development of rat brain. J Nutr Sci Vitaminol (Tokyo) 1985 Jun;31(3):305–315. [PubMed]
  • Jacobson MK, Amé JC, Lin W, Coyle DL, Jacobson EL. Cyclic ADP-ribose. A new component of calcium signaling. Receptor. 1995 Spring;5(1):43–49. [PubMed]
  • Melo SS, Meirelles MS, Jordão Júnior AA, Vannucchi H. Lipid peroxidation in nicotinamide-deficient and nicotinamide-supplemented rats. Int J Vitam Nutr Res. 2000 Dec;70(6):321–323. [PubMed]
  • Schneider F, Popa R, Mihalas G, Stefanigă P, Mihalas IG, Măties R, Mateescu R. Superiority of antagonic-stress composition versus nicergoline in gerontopsychiatry. Ann N Y Acad Sci. 1994 Jun 30;717:332–342. [PubMed]
  • Herrmann WM, Stephan K, Gaede K, Apeceche M. A multicenter randomized double-blind study on the efficacy and safety of nicergoline in patients with multi-infarct dementia. Dement Geriatr Cogn Disord. 1997 Jan-Feb;8(1):9–17. [PubMed]
  • Battaglia A, Bruni G, Ardia A, Sacchetti G. Nicergoline in mild to moderate dementia. A multicenter, double-blind, placebo-controlled study. J Am Geriatr Soc. 1989 Apr;37(4):295–302. [PubMed]
  • Thomas DE, Chung-A-On KO, Dickerson JW, Tidmarsh SF, Shaw DM. Tryptophan and nutritional status of patients with senile dementia. Psychol Med. 1986 May;16(2):297–305. [PubMed]
  • Shaw DM, Tidmarsh SF, Karajgi BM, Sweeney EA, Williams S, Elameer M, Twining C. Pilot study of amino acids in senile dementia. Br J Psychiatry. 1981 Dec;139:580–582. [PubMed]
  • Albert M, Smith LA, Scherr PA, Taylor JO, Evans DA, Funkenstein HH. Use of brief cognitive tests to identify individuals in the community with clinically diagnosed Alzheimer's disease. Int J Neurosci. 1991 Apr;57(3-4):167–178. [PubMed]
  • Morris Martha Clare, Evans Denis A, Bienias Julia L, Tangney Christine C, Bennett David A, Aggarwal Neelum, Wilson Robert S, Scherr Paul A. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA. 2002 Jun 26;287(24):3230–3237. [PubMed]
  • Morris Martha Clare, Evans Denis A, Bienias Julia L, Tangney Christine C, Wilson Robert S. Vitamin E and cognitive decline in older persons. Arch Neurol. 2002 Jul;59(7):1125–1132. [PubMed]
  • Evans Denis A, Bennett David A, Wilson Robert S, Bienias Julia L, Morris Martha Clare, Scherr Paul A, Hebert Liesi E, Aggarwal Neelum, Beckett Laurel A, Joglekar Rajiv, et al. Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status. Arch Neurol. 2003 Feb;60(2):185–189. [PubMed]
  • Rockett HR, Breitenbach M, Frazier AL, Witschi J, Wolf AM, Field AE, Colditz GA. Validation of a youth/adolescent food frequency questionnaire. Prev Med. 1997 Nov-Dec;26(6):808–816. [PubMed]
  • Morris MC, Colditz GA, Evans DA. Response to a mail nutritional survey in an older bi-racial community population. Ann Epidemiol. 1998 Jul;8(5):342–346. [PubMed]
  • Willett W, Stampfer MJ. Total energy intake: implications for epidemiologic analyses. Am J Epidemiol. 1986 Jul;124(1):17–27. [PubMed]
  • Morris Martha Clare, Tangney Christine C, Bienias Julia L, Evans Denis A, Wilson Robert S. Validity and reproducibility of a food frequency questionnaire by cognition in an older biracial sample. Am J Epidemiol. 2003 Dec 15;158(12):1213–1217. [PubMed]
  • Welsh KA, Butters N, Mohs RC, Beekly D, Edland S, Fillenbaum G, Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery. Neurology. 1994 Apr;44(4):609–614. [PubMed]
  • Albert M. Neuropsychological and neurophysiological changes in healthy adult humans across the age range. Neurobiol Aging. 1993 Nov-Dec;14(6):623–625. [PubMed]
  • Scherr PA, Albert MS, Funkenstein HH, Cook NR, Hennekens CH, Branch LG, White LR, Taylor JO, Evans DA. Correlates of cognitive function in an elderly community population. Am J Epidemiol. 1988 Nov;128(5):1084–1101. [PubMed]
  • Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. [PubMed]
  • Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res. 1990 Mar;31(3):545–548. [PubMed]
  • Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 1991 May 11;337(8750):1158–1159. [PubMed]
  • Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics. 1982 Dec;38(4):963–974. [PubMed]
  • Glynn RJ, Beckett LA, Hebert LE, Morris MC, Scherr PA, Evans DA. Current and remote blood pressure and cognitive decline. JAMA. 1999 Feb 3;281(5):438–445. [PubMed]
  • Hebert LE, Scherr PA, Beckett LA, Albert MS, Pilgrim DM, Chown MJ, Funkenstein HH, Evans DA. Age-specific incidence of Alzheimer's disease in a community population. JAMA. 1995 May 3;273(17):1354–1359. [PubMed]
  • Morris Martha Clare, Evans Denis A, Bienias Julia L, Tangney Christine C, Bennett David A, Aggarwal Neelum, Wilson Robert S, Scherr Paul A. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA. 2002 Jun 26;287(24):3230–3237. [PubMed]
  • Engelhart Marianne J, Geerlings Mirjam I, Ruitenberg Annemieke, van Swieten John C, Hofman Albert, Witteman Jacqueline C M, Breteler Monique M B. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA. 2002 Jun 26;287(24):3223–3229. [PubMed]
  • Seshadri Sudha, Beiser Alexa, Selhub Jacob, Jacques Paul F, Rosenberg Irwin H, D'Agostino Ralph B, Wilson Peter W F, Wolf Philip A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002 Feb 14;346(7):476–483. [PubMed]
  • Wang HX, Wahlin A, Basun H, Fastbom J, Winblad B, Fratiglioni L. Vitamin B(12) and folate in relation to the development of Alzheimer's disease. Neurology. 2001 May 8;56(9):1188–1194. [PubMed]
  • Riggs KM, Spiro A, 3rd, Tucker K, Rush D. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr. 1996 Mar;63(3):306–314. [PubMed]
  • Morris Martha Clare, Evans Denis A, Bienias Julia L, Tangney Christine C, Bennett David A, Aggarwal Neelum, Schneider Julie, Wilson Robert S. Dietary fats and the risk of incident Alzheimer disease. Arch Neurol. 2003 Feb;60(2):194–200. [PubMed]
  • Gorelick PB, Mangone CA. Vascular dementias in the elderly. Clin Geriatr Med. 1991 Aug;7(3):599–615. [PubMed]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group